Cencora (COR) Competitors

Cencora currently has a consensus target price of $380.25, indicating a potential upside of 41.25%. McKesson has a consensus target price of $968.87, indicating a potential upside of 30.67%. Given Cencora's higher probable upside, equities research analysts clearly believe Cencora is more favorable than McKesson.

In the previous week, McKesson had 18 more articles in the media than Cencora. MarketBeat recorded 30 mentions for McKesson and 12 mentions for Cencora. McKesson's average media sentiment score of 1.33 beat Cencora's score of 0.52 indicating that McKesson is being referred to more favorably in the news media.

Cencora has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market. Comparatively, McKesson has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market.

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.9%. McKesson pays an annual dividend of $3.28 per share and has a dividend yield of 0.4%. Cencora pays out 18.4% of its earnings in the form of a dividend. McKesson pays out 8.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has raised its dividend for 15 consecutive years and McKesson has raised its dividend for 17 consecutive years.

McKesson has a net margin of 1.18% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat McKesson's return on equity.

97.5% of Cencora shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 0.4% of Cencora shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.1% of Cardinal Health shares are owned by company insiders. Comparatively, 0.4% of Cencora shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Cencora has a net margin of 0.78% compared to Cardinal Health's net margin of 0.62%. Cencora's return on equity of 135.20% beat Cardinal Health's return on equity.

In the previous week, Cencora had 8 more articles in the media than Cardinal Health. MarketBeat recorded 12 mentions for Cencora and 4 mentions for Cardinal Health. Cardinal Health's average media sentiment score of 0.89 beat Cencora's score of 0.52 indicating that Cardinal Health is being referred to more favorably in the media.

Cardinal Health has higher earnings, but lower revenue than Cencora. Cencora is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Cardinal Health presently has a consensus target price of $241.80, indicating a potential upside of 23.01%. Cencora has a consensus target price of $380.25, indicating a potential upside of 41.25%. Given Cencora's higher possible upside, analysts clearly believe Cencora is more favorable than Cardinal Health.

Cardinal Health has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, Cencora has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market.

Cardinal Health pays an annual dividend of $2.04 per share and has a dividend yield of 1.0%. Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.9%. Cardinal Health pays out 31.2% of its earnings in the form of a dividend. Cencora pays out 18.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cardinal Health has increased its dividend for 29 consecutive years and Cencora has increased its dividend for 15 consecutive years. Cardinal Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Henry Schein has a net margin of 2.95% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat Henry Schein's return on equity.

In the previous week, Henry Schein had 7 more articles in the media than Cencora. MarketBeat recorded 19 mentions for Henry Schein and 12 mentions for Cencora. Henry Schein's average media sentiment score of 0.68 beat Cencora's score of 0.52 indicating that Henry Schein is being referred to more favorably in the media.

Cencora has higher revenue and earnings than Henry Schein. Cencora is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Henry Schein presently has a consensus price target of $86.83, suggesting a potential upside of 13.39%. Cencora has a consensus price target of $380.25, suggesting a potential upside of 41.25%. Given Cencora's stronger consensus rating and higher probable upside, analysts plainly believe Cencora is more favorable than Henry Schein.

Henry Schein has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market. Comparatively, Cencora has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market.

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.9% of Henry Schein shares are held by insiders. Comparatively, 0.4% of Cencora shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Cencora currently has a consensus target price of $380.25, suggesting a potential upside of 41.25%. Danaher has a consensus target price of $238.24, suggesting a potential upside of 30.38%. Given Cencora's higher possible upside, equities analysts plainly believe Cencora is more favorable than Danaher.

Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.9%. Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.9%. Cencora pays out 18.4% of its earnings in the form of a dividend. Danaher pays out 30.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has raised its dividend for 15 consecutive years and Danaher has raised its dividend for 2 consecutive years. Cencora is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

97.5% of Cencora shares are owned by institutional investors. Comparatively, 79.1% of Danaher shares are owned by institutional investors. 0.4% of Cencora shares are owned by insiders. Comparatively, 10.8% of Danaher shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Danaher has a net margin of 14.89% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat Danaher's return on equity.

In the previous week, Cencora had 4 more articles in the media than Danaher. MarketBeat recorded 12 mentions for Cencora and 8 mentions for Danaher. Danaher's average media sentiment score of 1.00 beat Cencora's score of 0.52 indicating that Danaher is being referred to more favorably in the news media.

Danaher has lower revenue, but higher earnings than Cencora. Cencora is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

Cencora has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market. Comparatively, Danaher has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.